Health Care & Life Sciences » Biotechnology | Port Erin Biopharma Investments Ltd.

Port Erin Biopharma Investments Ltd. | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
3,624.60
5,357.40
2,633.00
2,197.90
875.90
Total Assets
3,632.40
5,382.40
2,718.20
2,206.40
2,145.20
Provision for Risks & Charges
-
-
-
29.10
26.50
Other Liabilities
32.40
401.00
31.60
25.10
3.50
Total Liabilities
32.40
401.00
31.60
54.20
30.00
Common Equity (Total)
3,600.00
4,981.40
2,686.60
2,152.20
2,115.20
Total Shareholders' Equity
3,600.00
4,981.40
2,686.60
2,152.20
2,115.20
Total Equity
3,600.00
4,981.40
2,686.60
2,152.20
2,115.20
Liabilities & Shareholders' Equity
3,632.40
5,382.40
2,718.20
2,206.40
2,145.20
Short-Term Receivables
7.80
25.00
7.60
7.30
217.10
Investments - Total
-
-
77.50
1.10
1,052.20

About Port Erin Biopharma Investments

View Profile
Address
18 Athol Street
Douglas Isle of Man IM1 1JA
United Kingdom
Employees -
Website http://www.porterinbiopharma.com
Updated 09/14/2018
Port Erin Biopharma Investments Ltd. engages in the investment in the biotechnology and biopharmaceutical sectors. The company was founded on May 3, 2011 and is headquartered in Douglas, Isle of Man. .